Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration...
-- Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company...